当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:225.69亿  总市值:228.87亿
流通股本:15.77亿   总股本:15.99亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.14亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益781347.05万元,未分配利润331960.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1112828.47万元,负债331481.42万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入443,848,309.812,418,234,933.461,718,807,933.371,154,212,387
营业总成本406,874,077.192,107,110,191.821,488,300,078.09975,738,044.24
其他经营收益
营业利润131,054,857.36187,949,310.11140,353,629.7513,928,276.59
利润总额128,938,125.59166,112,393.23136,278,616.6712,042,491.96
净利润114,413,869.69125,157,091.43103,512,939.99-7,094,241.99
每股收益
其他综合收益-213,017,400106,250,00039,950,000
综合收益总额114,413,869.69338,174,491.43209,762,939.9932,855,758.01
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,329,045,639.344,546,332,984.655,912,282,709.356,727,743,135.54
非流动资产:
非流动资产合计6,799,239,065.427,524,256,256.617,339,582,207.347,274,758,697.41
资产总计11,128,284,704.7612,070,589,241.2613,251,864,916.6914,002,501,832.95
流动负债:
流动负债合计2,001,918,172.991,937,123,384.71,678,427,087.042,388,098,966.11
非流动负债:
非流动负债合计1,312,896,044.42597,073,860.22630,232,463.27848,104,682.44
负债合计3,314,814,217.412,534,197,244.922,308,659,550.313,236,203,648.55
所有者权益(或股东权益):
归属于母公司股东权益合计7,408,481,999.528,620,990,550.959,683,242,545.419,496,660,286.66
股东权益合计7,813,470,487.359,536,391,996.3410,943,205,366.3810,766,298,184.4
负债和股东权益合计11,128,284,704.7612,070,589,241.2613,251,864,916.6914,002,501,832.95
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计468,908,289.542,788,916,431.971,850,051,940.041,193,669,127.43
经营活动现金流出小计489,147,342.582,297,990,265.811,770,359,850.281,077,012,043.08
经营活动产生的现金流量净额-20,239,053.04490,926,166.1679,692,089.76116,657,084.35
投资活动产生的现金流量:
投资活动现金流入小计6,661,283.13192,895,570.81161,922,690.01191,389
投资活动现金流出小计144,889,103.18509,544,939.65357,253,150.1141,478,824.71
投资活动产生的现金流量净额-138,227,820.05-316,649,368.84-195,330,460.09-141,287,435.71
筹资活动产生的现金流量:
筹资活动现金流入小计977,260,053.13305,800,605.752,440,0002,440,000
筹资活动现金流出小计1,200,265,9272,889,984,280.21,969,865,412.911,204,374,595.64
筹资活动产生的现金流量净额-223,005,873.87-2,584,183,674.45-1,967,425,412.91-1,201,934,595.64
汇率变动对现金及现金等价物的影响-1,147,114.85-951,793.34908,358.771,233,445.54
现金及现金等价物净增加额-382,619,861.81-2,410,858,670.47-2,082,155,424.47-1,225,331,501.46
期末现金及现金等价物余额965,624,283.731,348,244,145.541,676,947,391.542,533,771,314.55
补充资料:
现金及现金等价物的净增加额--2,410,858,670.47--1,225,331,501.46
TOP↑